Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Large Cap Equities LLY
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags Analyst Ratings BMY Downgrades
From Benzinga
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
Tickers NVS
Tags NVS Recent Press Releases Market News
From Motley Fool
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
Tickers NEWS NVS
Tags General Briefs Stories That Matter
From Benzinga
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
Tickers GLUE NEWS NVS
Tags General Briefs Movers
From Benzinga
3 Absurdly Cheap Stocks That Pay High Dividends
Tickers GILD MRK NVS
Tags NVS Recent Press Releases Market News
From Motley Fool
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
Tickers CTLT NEWS NVO NVS
Tags Health Care NVO AI Generated
From Benzinga
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
Tickers NEWS NVS SNY
Tags Benzinga Stories That Matter Biotech
From Benzinga
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
Tickers NVS
Tags Market News NVS Recent Press Releases
From Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
Tickers ALPMF ALPMY APLS NEWS
Tags Benzinga Stories That Matter ALPMF
From Benzinga
Looking Into Novartis's Recent Short Interest
Tickers NVS
Tags Short Sellers NVS Market News
From Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
Tickers ABBV NVS
Tags ABBV Recent Press Releases NVS
From Motley Fool
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
Tickers NEWS NVS OKUR
Tags Initiation Analyst Ratings NVS
From Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
Tickers AZN LLY NEWS NVO
Tags SNY News Large Cap
From Benzinga
Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
Tickers INCY NEWS NVS
Tags General Benzinga Stories That Matter
From Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Tickers NEWS NVS SNY
Tags SNY Briefs Large Cap
From Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
Tickers ACET ANIP NEWS NVS
Tags Market News NVS Markets
From Benzinga
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
Tickers APP ASO ATOS CAC
Tags News SUPN CAC
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags Top Stories TAK Health Care
From Benzinga
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
Tickers NEWS NVO NVS
Tags Health Care NVO Trading Ideas
From Benzinga
S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Tickers AI CE CHPT CNM
Tags AI Benzinga COLL
From Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
Tickers AMGN AZN BMY JNJ
Tags Government Briefs Stories That Matter
From Benzinga
Novartis' Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study
Tickers NEWS NVS
Tags Top Stories Health Care Large Cap
From Benzinga
Siemens Healthineers To Buy Novartis Diagnostics To Bolster Cancer Scan Business In $220M Deal
Tickers NEWS NVS
Tags Briefs Biotech Benzinga
From Benzinga
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
Tickers DXCM NVS
Tags DXCM Recent Press Releases NVS
From Motley Fool
Judge Rules Against Novartis' Effort To Halt Generic Launch Of Its Top-Selling Heart Disease Drug
Tickers NEWS NVS
Tags NVS Market News News
From Benzinga
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease
Tickers NEWS NVS
Tags FDA General Briefs
From Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
Tickers NEWS NVS RARE TMO
Tags Briefs Stories That Matter Benzinga
From Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
Tickers ASIA AZN BMY NEWS
Tags Pooja Rajkumari Biotech Benzinga
From Benzinga
Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
Tickers NVS
Tags Market News Recent Press Releases NVS
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.